Fosfomycin-Containing Second-Line Treatment For Helicobacter pylori Infection

[1]  H. Goossens,et al.  Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption , 2012, Gut.

[2]  F. I. Téllez-Ávila,et al.  Pantoprazol, levofloxacina y amoxicilina como tratamiento de primera línea para la erradicación de Helicobacter pylori en Guatemala: efectividad en un país en vías de desarrollo , 2012 .

[3]  Deng-Chyang Wu,et al.  The Efficacy of Second‐Line Anti‐Helicobacter pylori Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study , 2012, Helicobacter.

[4]  Yunsheng Yang,et al.  Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication , 2012, Gastroenterology research and practice.

[5]  Deng-Chyang Wu,et al.  Randomized Comparison of Two Non‐Bismuth‐Containing Second‐line Rescue Therapies for Helicobacter pylori , 2012, Helicobacter.

[6]  A. Tursi,et al.  Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection. , 2012, Journal of gastrointestinal and liver diseases : JGLD.

[7]  Gian Franco Gensini,et al.  Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report , 2012, Gut.

[8]  M. Ström,et al.  Adalimumab in budesonide and methotrexate refractory collagenous colitis , 2012, Scandinavian journal of gastroenterology.

[9]  J. Llorca,et al.  Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain. , 2012, The Journal of antimicrobial chemotherapy.

[10]  A. Salas,et al.  Efficacy of anti-TNF therapies in refractory severe microscopic colitis. , 2011, Journal of Crohn's & colitis.

[11]  H. MochizukiTamayo,et al.  Antimicrobial susceptibility of helicobacter pylori to levofloxacin determined in a miniwell format and disk diffusion tests using egg yolk agar , 2011 .

[12]  R. Hunt,et al.  World Gastroenterology Organisation Global Guideline: Helicobacter pylori in Developing Countries , 2011, Journal of digestive diseases.

[13]  P. Malfertheiner,et al.  Helicobacter pylori in developing countries , 2010 .

[14]  P. Apfalter,et al.  In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[15]  O. Jardetzky,et al.  Phosphonomycin: Structure and Synthesis , 1969, Science.

[16]  H. B. Woodruff,et al.  Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces , 1969, Science.